<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02071706</url>
  </required_header>
  <id_info>
    <org_study_id>114-2013-GES-0010</org_study_id>
    <nct_id>NCT02071706</nct_id>
  </id_info>
  <brief_title>Clinical Evaluation of an Integrated PET/MRI System</brief_title>
  <acronym>PET/MR_ZURICH</acronym>
  <official_title>Clinical Evaluation of an Integrated PET/MRI System</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>GE Healthcare</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>GE Healthcare</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigational PET/MRI scanner, including attenuation correction method, is capable of
      producing diagnostic quality images and appropriate device functionality per user feedback.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2014</start_date>
  <completion_date type="Actual">August 2014</completion_date>
  <primary_completion_date type="Actual">August 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number Usable PET/MRI Image Sets</measure>
    <time_frame>1 day</time_frame>
    <description>The number PET/MRI image sets determined usable by a radiologist on a yes/no binary scale</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Diagnostic Quality Images</measure>
    <time_frame>1 day</time_frame>
    <description>Number of images sets deemed diagnostic quality by the investigator</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">62</enrollment>
  <condition>Subjects With Clinical Indication for PET/CT</condition>
  <arm_group>
    <arm_group_label>Single-Arm PET/MRI</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Single-group evaluation of PET/MRI for diagnostic quality of image</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>PET/MRI system</intervention_name>
    <description>Enrolled subject undergoes PET/MR scan</description>
    <arm_group_label>Single-Arm PET/MRI</arm_group_label>
    <other_name>PET/MRI system inlcudes:</other_name>
    <other_name>3T MR750w Magnet</other_name>
    <other_name>MR750w XRMw Gradient</other_name>
    <other_name>PET/MRI Body Coil</other_name>
    <other_name>Photon Detection Ring and PET Detectors</other_name>
    <other_name>PET/MR Patient Table</other_name>
    <other_name>PET Electronics (mounted to magnet) and Cables</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Subject must have a clinical indication for a PET/CT exam

          2. Subject must be at least eighteen (18) years of age; and

          3. Female subjects that are determined to be non-pregnant by a physician investigator or
             are demonstrated non-pregnant by negative urine pregnancy test administered within the
             24 hour period before PET/CT imaging; and

          4. Subject must be able to hear and understand instructions without assistive devices;
             and

          5. Subject must provide written informed consent; and

          6. Subject has the necessary mental capacity to understand instructions, and is able to
             comply with protocol requirements; and

          7. Subject is able to remain still for duration of imaging procedure (approximately 60
             minutes total for PET/MRI); and

          8. Subject must be able to participate in a PET/MR imaging session within 2 hours of
             concluding their PET/CT exam and within 4 hours of PET radiotracer administration.

        Exclusion Criteria:

          1. Subjects who have any axial diameter larger than 55 cm; or

          2. Subjects with a weight greater than 227 kgs; or

          3. Subjects that have metallic/conductive or electrically/magnetically active implants
             without MR Safe or MR Conditional labeling, with the exception of dental
             devices/fillings, surgical clips, and surgical staples determined to be safe for MRI
             scanning by a physician investigator; or

          4. Subjects that have implants with MR Unsafe labeling; or

          5. Subjects that have implants labeled as MR Conditional by the manufacturer for which
             the allowable conditions are not expected to be achieved by the MR/PET environment or
             scan protocol ; or

          6. Subjects who have a contraindication to MRI according to the screening policy of the
             participating site
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tibor Duliskovich, Medical Doctor</last_name>
    <role>Study Director</role>
    <affiliation>GE Healthcare</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>UniversitätsSpital Zürich</name>
      <address>
        <city>Zurich</city>
        <zip>CH-8091</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>January 2019</verification_date>
  <study_first_submitted>February 23, 2014</study_first_submitted>
  <study_first_submitted_qc>February 25, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 26, 2014</study_first_posted>
  <results_first_submitted>July 20, 2015</results_first_submitted>
  <results_first_submitted_qc>January 4, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">April 8, 2019</results_first_posted>
  <last_update_submitted>January 4, 2019</last_update_submitted>
  <last_update_submitted_qc>January 4, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">April 8, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>

  <clinical_results>

    <participant_flow>
      <recruitment_details>First participant enrolled on January 20, 2014. Last participant enrolled on July 07, 2014 at the Zurich University Hospital site. Subject or participant recruitment was prematurely terminated because the sponsor had determined that sufficient data was collected for regulatory submissions</recruitment_details>
      <pre_assignment_details>Subjects/participants were enrolled in one of three study segments and received a clinically indicated PET/CT exam with radiopharmaceutical injection followed by PET/MRI scanning. Up to two subject datasets (each dataset labelled with unique subject ID) can be collected from one enrolled participant/subject.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Single-Arm PET/MRI</title>
          <description>Single-group evaluation of PET/MRI for diagnostic quality of image
PET/MRI system: Enrolled subject undergoes PET/MR scan</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="62"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="59"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Single-Arm PET/MRI</title>
          <description>Single-group evaluation of PET/MRI for diagnostic quality of image
PET/MRI system: Enrolled subject undergoes PET/MR scan</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="62"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age, Customized</title>
          <description>Patient/participant must be at least 18 years of age. Eligible subjects were allowed to participate up to two times.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Equal to or more than 18 years of age</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="62"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="23"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number Usable PET/MRI Image Sets</title>
        <description>The number PET/MRI image sets determined usable by a radiologist on a yes/no binary scale</description>
        <time_frame>1 day</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Single-Arm PET/MRI</title>
            <description>Single-group evaluation of PET/MRI for diagnostic quality of image
PET/MRI system: Enrolled subject undergoes PET/MR scan</description>
          </group>
        </group_list>
        <measure>
          <title>Number Usable PET/MRI Image Sets</title>
          <description>The number PET/MRI image sets determined usable by a radiologist on a yes/no binary scale</description>
          <units>Usable image sets</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="62"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="70"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Diagnostic Quality Images</title>
        <description>Number of images sets deemed diagnostic quality by the investigator</description>
        <time_frame>1 day</time_frame>
        <population>PET/MR Scans with qualitative comments</population>
        <group_list>
          <group group_id="O1">
            <title>Single-Arm PET/MRI</title>
            <description>Single-group evaluation of PET/MRI for diagnostic quality of image
PET/MRI system: Enrolled subject undergoes PET/MR scan</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Diagnostic Quality Images</title>
          <description>Number of images sets deemed diagnostic quality by the investigator</description>
          <population>PET/MR Scans with qualitative comments</population>
          <units>Image sets</units>
          <param>Number</param>
          <units_analyzed>Number of Image Sets</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="62"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Number of Image Sets</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="74"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="67"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>approximately 7 months</time_frame>
      <desc>subject participants were considered to be actively enrolled from the time the subject entered the scan room for their PET/MR procedure to the time the subject left the PET/MR scan room. AE monitoring were conducted starting from the subject participants signing off the informed consent form until the subject participant left the PET/MR scan room</desc>
      <group_list>
        <group group_id="E1">
          <title>Single-Arm PET/MRI</title>
          <description>Single-group evaluation of PET/MRI for diagnostic quality of image
PET/MRI system: Enrolled subject undergoes PET/MR scan</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="62"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_vocab>MedRA</default_vocab>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="62"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Warming</sub_title>
                <description>the two reported AEs (Warming) were considered to be anticipated, mild, and probably device-related</description>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="62"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Yvonne Celestial</name_or_title>
      <organization>GE Healthcare</organization>
      <phone>+33625023857</phone>
      <email>MarieYvonne.CELESTIAL@ge.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

